Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT04994145
Other study ID # PD-612416
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date September 1, 2021
Est. completion date December 15, 2021

Study information

Verified date December 2021
Source Molnlycke Health Care AB
Contact Camilla Fardell, Ph.D.
Phone +46317223402
Email camilla.fardell@molnlycke.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a retrospective, observational (non-interventional), single-arm, single-centre, post-market clinical investigation designed to verify clinical performance and safety of Mepilex Border Post-Op when used according to clinical practice for post-operative wounds in a large and broad population. The clinical investigation will consist of a retrospective medical record review, which will be completed with data from up to 450 female and male adult subjects who were treated with Mepilex Border Post-Op following elective hip or knee replacement at one clinic in Belgium between January 2016 and February 2021.


Description:

Mepilex Border Post-Op is a CE-marked class IIa medical device developed, manufactured and marketed by Mölnlycke Health Care AB. This is a retrospective, observational (non-interventional), single-arm, single-centre, post-market clinical investigation designed to verify clinical performance and safety of Mepilex Border Post-Op when used according to clinical practice for post-operative wounds in a large and broad population. The overall objective of this investigation is to confirm the clinical performance of Mepilex Border Post-Op for post-operative wounds when used according to clinical practice, by assessing dressing wear time from day of surgery to end of dressing use. The clinical investigation will consist of a retrospective medical record review, which will be completed with data from up to 450 female and male adult subjects who were treated with Mepilex Border Post-Op following elective hip or knee replacement at one clinic in Belgium between January 2016 and February 2021. The data collected for each subject will include those generated in relation to the surgery itself as well as the pre- and post-surgery phases. There is no available data for subjects treated with an alternative to Mepilex Border Post-Op to use as a control group, however, the pre-surgery data will serve as control for some endpoints. The treatment the subjects received at the clinic included pre-surgery visits, the surgery itself, a short in-patient stay following surgery, and post-surgery follow-up visits at approximately 14 days, 1.5 months, 3 months, 6 months, and 1 year. In addition, the subjects used the commercially available mobile health application moveUP Therapy to support their rehabilitation. The subjects' rehabilitation was tracked and aided with moveUP Therapy as it allows (1) subjects to answer a number of questionnaires; (2) subjects to communicate with their surgeon and physical therapist via a chat function in the app; and (3) subject-specific log entries by the surgeon and physical therapist. The data to be used in this retrospective investigation will be extracted exclusively from moveUP Therapy. Eligible subjects/medical records will be identified by site personnel through screening moveUP Therapy. Only data from subjects who have consented to the use of their data related to the surgery in an anonymous way for medical research and scientific publications will be extracted. The investigational device, Mepilex Border Post-Op, was applied as part of the surgery. In the rare event that a dressing change would be required, the subjects were provided with spare dressings and instructions for how to do the change by the treating surgeon or clinic nurse. These instructions included only changing the dressing once at least three corners of the dressing were stained with blood, and to consult the treating surgeon or clinic nurse by sending a moveUP Therapy chat message with a picture of the dressing requesting advice on whether to change or not. Dressing wear time will be derived from up to three sources: 1. how frequently the subjects have answered the question "Is the dressing dry?" with "Yes, it was changed today"; 2. review of potential Health Care Professional log entries for evidence of dressing change(s); and 3. review of potential moveUP Therapy chat messages, including photographs, for evidence of dressing change(s). Total number of dressings per subject will be derived from the same information as dressing wear time.


Recruitment information / eligibility

Status Recruiting
Enrollment 560
Est. completion date December 15, 2021
Est. primary completion date December 15, 2021
Accepts healthy volunteers No
Gender All
Age group 18 Years to 100 Years
Eligibility Inclusion Criteria: 1. Underwent elective knee or hip surgery between January 2016 and February 2021 at the Medisch Centrum Latem, Belgium. 2. Post-operative wound treated with Mepilex Border Post-Op 3. Documented consent in moveUP Therapy 4. Documented consent at Medisch Centrum Latem during pre-op consultation Exclusion Criteria: 1. Subject missing all answers to the moveUP Therapy question "Is the dressing dry?"

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Belgium Medisch Centrum Latem Sint-Martens-Latem

Sponsors (1)

Lead Sponsor Collaborator
Molnlycke Health Care AB

Country where clinical trial is conducted

Belgium, 

Outcome

Type Measure Description Time frame Safety issue
Primary Dressing wear time Dressing wear time from day of surgery to end of dressing use From day of surgery to end of dressing use (up to one month)
Secondary Total number of dressings per subject Total number of dressings/subject from day of surgery to end of dressing use From day of surgery to end of dressing use (up to one month)
Secondary Time to dressing strikethrough Time to dressing strikethrough from day of surgery to end of dressing use From day of surgery to end of dressing use (up to one month)
Secondary Change in physical activity level Percentage and absolute change in physical activity level (daily step count) pre-surgery to end of dressing use Pre-surgery to end of dressing use (up to one month)
Secondary Change in the EQ-5D Percentage and absolute change in the EQ-5D results pre-surgery to day 83. Pre-surgery to day 83 post surgery
Secondary Change in KOOS or HOOS pain subscale score Percentage and absolute change in the KOOS or HOOS pain subscale score pre-surgery to day 42 and day 83 pre-surgery to day 42 and day 83 post surgery
Secondary Change in KOOS or HOOS symptoms subscale score Percentage and absolute change in the KOOS or HOOS symptoms subscale score pre-surgery to day 42 and day 83 pre-surgery to day 42 and day 83 post surgery
Secondary Change in KOOS or HOOS activities of daily living subscale score Percentage and absolute change in the KOOS or HOOS activities of daily living subscale score pre-surgery to day 42 and day 83 pre-surgery to day 42 and day 83 post surgery
Secondary Change in KOOS or HOOS sport and recreation function subscale score Percentage and absolute change in the KOOS or HOOS sport and recreation function subscale score pre-surgery to day 42 and day 83 pre-surgery to day 42 and day 83 post surgery
Secondary Change in KOOS or HOOS joint-related quality of life subscale score Percentage and absolute change in the KOOS or HOOS joint-related quality of life subscale score pre-surgery to day 42 and day 83 pre-surgery to day 42 and day 83 post surgery
Secondary Dressing showerability Number of incidences (percentage and absolute) of dressing detachment due to subject showering or using water in other ways for personal hygiene reasons From day of surgery to end of dressing use (up to one month)
See also
  Status Clinical Trial Phase
Recruiting NCT04081792 - Optimal Antibiotics for Operated Diabetic Foot Infections N/A
Recruiting NCT02685761 - Skin Incisions and Wound Complication Rates for C-sections in Obese Women N/A
Completed NCT01297322 - RESPECT Trial - (Rapid Extravascular Sealing Via PercutanEous Collagen ImplanT) N/A
Not yet recruiting NCT03872544 - Short Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Completed NCT03193021 - AMBULATE: Cardiva Mid-Bore VVCS vs. Manual Compression for Multiple Femoral Venous Access Sites, 6 - 12F ID N/A
Not yet recruiting NCT06028854 - Blood Characteristics and Abdominal Emergency Surgery
Completed NCT05646121 - Suprasorb® A + Ag in the Treatment of Wounds at Risk of Infection and Infected Wounds
Enrolling by invitation NCT03880188 - Long Term Status of Free Dermal Fat Autografts for Complex Craniofacial Wounds
Recruiting NCT06342479 - Discharge Training for Patients With Intertrochanteric Fracture N/A
Recruiting NCT03561376 - Zinc Oxide Versus Petrolatum Following Skin Surgery Early Phase 1
Recruiting NCT04439552 - fMRI and IVCM Cornea Microscopy of CXL in Keratoconus
Completed NCT05618912 - Scar Appearance After Postoperative Hydrocolloid Dressing Versus Standard Petrolatum Ointment N/A
Completed NCT04596163 - Transversus Thoracis Muscle Plane Block for Sternotomy Pain in Cardiac Surgery N/A
Completed NCT04036344 - Buddy Relationships in DermatoloGic Excisions for Skin Cancer N/A
Completed NCT05791721 - Effect of Preemptive Etoricoxib and Dexamethasone on Wound Healing and Clinical Parameters After Third Molar Surgery Phase 4
Recruiting NCT06073678 - Photobiomodulation in Palate Wounds: Somatosensorial Evaluation N/A
Completed NCT05252260 - Comparison of Diode Laser-Assisted Vestibuloplasty And Conventional Vestibuloplasty N/A
Withdrawn NCT04053946 - Clinical Assessment of Next Science Wound Gels in Healing Below the Knee Amputation Surgical Wound Compared to SOC N/A
Recruiting NCT04740775 - LiquiBand® Exceed™ and LiquiBand® Rapid™ for General Surgery Procedures N/A
Terminated NCT04712019 - Evaluating Edema and Range of Motion Using Negative Pressure Therapy vs. Standard Surgical Dressing in Bilateral TKA N/A